Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA6 | P23280 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | HTR6 | P50406 | 3/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | ITGAV | P06756 | 1/20 | 0.35 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1682100 | 0.81 | GAA (0.50) | GAACA1CA2CA6CA9 | |
| SCHEMBL9745397 | 0.79 | GAA (0.37) | GAACA1CA2CA6CA9 | |
| SCHEMBL29469861 | 0.77 | CA2 (0.56) | GAACA1CA2CA6CA9 | |
| SCHEMBL2893446 | 0.77 | CA1 (0.39) | GAACA1CA2CA6CA9 | |
| SCHEMBL29566694 | 0.77 | TSHR (0.44) | GAACA1CA2CA6CA9 | |
| SCHEMBL7990343 | 0.77 | GAA (0.36) | GAACA1CA2CA6CA9 | |
| SCHEMBL745249 | 0.77 | ALDH1A1 (0.44) | GAACA1CA2CA6CA9 | |
| SCHEMBL2887767 | 0.77 | ELANE (0.48) | GAACA1CA2CA6CA9 | |
| SCHEMBL1471236 | 0.77 | CA2 (0.56) | GAACA1CA2CA6CA9 | |
| SCHEMBL648702 | 0.77 | BCAT2 (0.40) | GAACA1CA2CA6CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5196437-A | Macrolide | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1993-03-23 | — | — | US | claimed |
| CN-112930352-B | Silylamine compounds and latent curing agents containing the same | 广荣化学株式会社 | 2024-02-13 | — | — | CN | disclosed |
| US-20220119583-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2022-04-21 | — | — | US | disclosed |
| EP-3875461-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | Koei Chemical Company, Limited (JP) | 2021-09-08 | — | — | EP | disclosed |
| CN-112930352-A | Silylamine compound and latent curing agent containing the same | 广荣化学株式会社 | 2021-06-08 | — | — | CN | disclosed |
| US-4379917-A | 6\"-(Substituted)-apramycin antibiotic derivatives and intermediates and starting materials therefor | ELI LILLY AND COMPANY (US) | 1983-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119583-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | CDKN1A, SIRT2, H1-4 | GAA 1082/4885CA1 953/4885CA2 994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.